Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Standard ART Practice vs. Trophectoderm Biopsy, Whole Chromosome Analysis by Next Generation Sequencing, and Replacement of a Single Euploid Embryo

NCT01946945 is registered in ClinicalTrials.gov with Reprogenetics as lead sponsor.

NCT NCT01946945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01946945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Standard ART Practice vs. Trophectoderm Biopsy, Whole Chromosome Analysis by Next Generation Sequencing, and Replacement of a Single Euploid Embryo
Lead sponsor
Reprogenetics
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2013
Completion date
Not reported
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infertility, recurrent pregnancy loss